# Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine

> **NCT00259272** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 141 (actual)

## Conditions studied

- Bipolar Disorder I or II

## Interventions

- **DRUG:** olanzapine

## Key facts

- **NCT ID:** NCT00259272
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2009-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259272, "Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00259272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*